Literature DB >> 228102

Glycolipids in human lung carcinoma of histologically different types.

Y Yoda, S Gasa, A Makita, Y Fujioka, Y Kikuchi, M Hashimoto.   

Abstract

Glycolipids were isolated from primary human lung carcinoma tissue of various histologic types: adenocarcinoma, squamous cell carcinoma, and undifferentiated small cell carcinoma. Each type of carcinoma had a characteristic glycolipid pattern. The major glycolipids isolated were ceramide monohexosides, ceramide dihexosides, ceramide trihexosides, globoside, and hematoside. Squamous cell carcinoma and undifferentiated small cell carcinoma showed marked increases of ceramide monohexosides and dihexosides. Adenocarcinoma had a much higher level of the sulfatide (ceramide 3-sulfate-galactoside) as compared to squamous cell carcinoma, undifferentiated small cell carcinoma, or normal lung tissue. Embryonic tissue had more significant levels of sulfatide than did the other carcinomas. Adenocarcinoma had significantly lower levels of glycolipids due mainly to a decrease in the amount of ceramide monohexosides and dihexosides and hematoside.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228102

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

3.  High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma.

Authors:  Anne-Marie Lemay; Olivier Courtemanche; Timothy A Couttas; Giuleta Jamsari; Andréanne Gagné; Yohan Bossé; Philippe Joubert; Anthony S Don; David Marsolais
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

4.  Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity.

Authors:  Zoran V Popovic; Roger Sandhoff; Tjeerd P Sijmonsma; Sylvia Kaden; Richard Jennemann; Eva Kiss; Edgar Tone; Frank Autschbach; Nick Platt; Ernst Malle; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

5.  Immunization of A4galt-deficient mice with glycosphingolipids from renal cell cancers resulted in the generation of anti-sulfoglycolipid monoclonal antibodies.

Authors:  Reiko Ando; Noriyo Tokuda; Tokunori Yamamoto; Kazutaka Ikeda; Noboru Hashimoto; Ryo Taguchi; Xiaoen Fan; Keiko Furukawa; Yukio Niimura; Akemi Suzuki; Momokazu Goto; Koichi Furukawa
Journal:  Glycoconj J       Date:  2016-02-16       Impact factor: 2.916

6.  The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.

Authors:  Stefan Porubsky; Malin Nientiedt; Maximilian C Kriegmair; Jörn-Helge Heinrich Siemoneit; Roger Sandhoff; Richard Jennemann; Hendrik Borgmann; Timo Gaiser; Cleo-Aron Weis; Philipp Erben; Thomas Hielscher; Zoran V Popovic
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

7.  Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.

Authors:  Jaroslaw Suchanski; Jedrzej Grzegrzolka; Tomasz Owczarek; Pawel Pasikowski; Aleksandra Piotrowska; Bartlomiej Kocbach; Aleksandra Nowak; Piotr Dziegiel; Andrzej Wojnar; Maciej Ugorski
Journal:  Breast Cancer Res       Date:  2018-11-06       Impact factor: 6.466

8.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct

9.  Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells.

Authors:  T Kobayashi; K Honke; K Kamio; N Sakakibara; S Gasa; N Miyao; T Tsukamoto; I Ishizuka; T Miyazaki; A Makita
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.